Slate Medicines

Business Services · North Carolina, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

Raleigh, North Carolina, United States

Revenue

<$5 Million

Industry

Business Services Research & Development

About Slate Medicines

Slate Medicines is a biotech company focused on advancing next generation therapeutics for migraine and other headache disorders. The Companys lead program, SLTE-1009, is a potential best-in-class subcutaneous anti-PACAP for the prevention of migraine and other headache disorders. The company is backed by leading healthcare investors including RA Capital Management, Forbion, Foresite Capital, and an additional undisclosed biotech investor.Explore more
Slate Medicines's Social MediaSIC Code 87,873NAICS Code 54,541Show more

Slate Medicines Org Chart

PhoneEmail
JU
United States flag for contact location.

Chief Financial Officer

PhoneEmail
NB
United States flag for contact location.

President & Chief Operating Officer

PhoneEmail
Roger Cady, Chief Medical Officer at Slate Medicines
United States flag for contact location.

Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
KM
United States flag for contact location.

Controller

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
Illustration of an envelope

Top Business Services Companies

Frequently Asked Questions Regarding Slate Medicines

What is Slate Medicines's official website?
Slate Medicines's official website is www.slatemedicines.com
What is Slate Medicines's Revenue?
Slate Medicines's revenue is <$5 Million
What is Slate Medicines's SIC code?
Slate Medicines's SIC: 87,873
What is Slate Medicines's NAICS code?
Slate Medicines's NAICS: 54,541
How many employees does Slate Medicines have?
Slate Medicines has 1-10 employees
What industry does Slate Medicines belong to?
Slate Medicines is in the industry of: Business Services, Research & Development
What companies has Slate Medicines acquired?
Slate Medicines has acquired the companies: Fulcrum Therapeutics
Who is the CFO of Slate Medicines?
Slate Medicines's CFO is John Umstead
What does Slate Medicines do?

Slate Medicines is a biotech company focused on advancing next generation therapeutics for migraine and other headache disorders. The Companys lead program, SLTE-1009, is a potential best-in-class subcutaneous anti-PACAP for the prevention of migraine and other headache disorders. The company is backed by leading healthcare investors including RA C... apital Management, Forbion, Foresite Capital, and an additional undisclosed biotech investor.Read More

What are Slate Medicines social media links?
Slate Medicines Linkedin page
Who invested in Slate Medicines?
Slate Medicines has 3 investors including Foresite Capital, Forbion and RA Capital Management.
Is Slate Medicines a public company?
Slate Medicines is private company therefore does not currently have an official ticker symbol
See more information about Slate Medicines

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.